Article
Abbott's UroVysion DNA probe assay has been approved by the FDA for use as an aid in initial diagnosis of bladder cancer in patients with hematuria and suspected of having bladder cancer.
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.